Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Core Viewpoint - Lifecore Biomedical and PolyPeptide Laboratories have signed a collaboration agreement to provide an integrated solution for peptide-based pharmaceutical customers in the U.S. [1][2] Group 1: Collaboration Details - The collaboration will combine PolyPeptide's capabilities in peptide manufacturing with Lifecore's expertise in formulation, fill/finish, and packaging [2] - The aim is to offer a seamless transition between drug substance and drug product, helping customers accelerate development timelines and reduce costs and risks [2][3] Group 2: Strategic Benefits - The partnership is expected to optimize product development activities through collaborative studies and streamline the supply chain to help customers meet development milestones [3] - By aligning technical and commercial strengths, the companies plan to support laboratory transfers, equipment comparability, method transfer, and release testing, ensuring quality throughout the process [4] Group 3: Company Profiles - PolyPeptide Laboratories is a specialized CDMO for peptide-based active pharmaceutical ingredients, serving a fast-growing market and offering comprehensive solutions from early-stage development to commercial supply [5] - Lifecore Biomedical is a fully integrated CDMO with over 40 years of expertise in developing and manufacturing sterile injectable pharmaceutical products, including complex formulations [6]